STA-5312

· Synta Pharmaceuticals Corp.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for STA-5312, covering 2008-12-04 to 2014-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]